Topics

Hormone Medicine

Core hormone optimization and bioidentical hormone replacement — the foundation of Dr. Rouzier's teaching.

Supporting evidence

Highest quality evidence

Published studies tagged to Hormone Medicine, ordered by evidence strength. Inspect design and limitations before applying findings.

International journal of impotence research2022PMID 34999717

Testosterone replacement therapy and cardiovascular disease.

Contemporary evidence does not support the historical concern that testosterone replacement therapy broadly increases cardiovascular risk in appropriately selected men; benefits and risks depend on indication, formulation, monitoring, and baseline cardiovascular status.

ReviewEvidence: ModerateRelevance: HighRouzier commentary
Testosterone & Cardiovascular Risk
OpenPublished November 2022Strength Moderate · Relevance High

Recent studies

2022Evidence: Moderate

Testosterone replacement therapy and cardiovascular disease.

International journal of impotence research

Contemporary evidence does not support the historical concern that testosterone replacement therapy broadly increases cardiovascular risk in appropriately selected men; benefits and risks depend on indication, formulation, monitoring, and baseline cardiovascular status.

Common clinical questions

What is the current evidence on Hormone Medicine?What has Dr. Rouzier taught about Hormone Medicine?Compare key studies on Hormone Medicine

Evidence timeline

  1. 2010Early concern
  2. 2014Observational controversy
  3. 2018More RCT evidence
  4. 2022Stronger evidence synthesis
  5. 2024Current evidence

Related topics

BHRT FoundationsMonitoring & Complex CasesMen's Hormone HealthWomen's Hormone HealthHormones & CancerThyroid OptimizationInsulin Resistance & Metabolic HealthChronic Disease & HormonesLongevity & Healthy AgingLifestyle MedicineEndocrine Disruptors